U.S. Capital Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1M	Buy	2,042 +428	+27%	+$232K	0.03%	515
2025 Q4	$935K	Sell	1,614 -257	-14%	-$145K	0.02%	510
2025 Q3	$908K	Buy	1,871 +92	+5%	+$42.8K	0.02%	490
2025 Q2	$721K	Buy	1,779 +95	+6%	+$39.7K	0.02%	508
2025 Q1	$838K	Sell	1,684 -33	-2%	-$17.9K	0.03%	460
2024 Q4	$893K	Buy	1,717 +26	+2%	+$14.3K	0.03%	444
2024 Q3	$1.05M	Sell	1,691 -119	-7%	-$70.4K	0.04%	349
2024 Q2	$1M	Sell	1,810 -177	-9%	-$101K	0.04%	345
2024 Q1	$1.15M	Sell	1,987 -4,960	-71%	-$2.78M	0.04%	321
2023 Q4	$3.69M	Sell	6,947 -1,659	-19%	-$803K	0.15%	147
2023 Q3	$4.36M	Buy	8,606 +175	+2%	+$93.3K	0.2%	113
2023 Q2	$4.4M	Buy	8,431 +119	+1%	+$64.2K	0.21%	112
2023 Q1	$4.79M	Sell	8,312 -548	-6%	-$309K	0.22%	105
2022 Q4	$4.88M	Buy	8,860 +602	+7%	+$319K	0.23%	99
2022 Q3	$4.19M	Buy	8,258 +67	+0.8%	+$37.5K	0.21%	105
2022 Q2	$4.45M	Sell	8,191 -1,497	-15%	-$824K	0.2%	108
2022 Q1	$5.72M	Sell	9,688 -231	-2%	-$133K	0.21%	103
2021 Q4	$6.62M	Buy	9,919 +56	+0.6%	+$35K	0.26%	87
2021 Q3	$5.63M	Buy	+9,863	New	+$5.41M	0.24%	100

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

U.S. Capital Wealth Advisors's TMO Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 27% in Q1 2026, buying an estimated $232K and bringing the position to 2,042 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #515.

U.S. Capital Wealth Advisors first reported a position in TMO in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.62M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

U.S. Capital Wealth Advisors held 2,042 shares of Thermo Fisher Scientific worth $1M as of Q1 2026.
U.S. Capital Wealth Advisors bought 428 Thermo Fisher Scientific shares in Q1 2026, an estimated $232K.
Thermo Fisher Scientific made up 0.03% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #515 holding.
U.S. Capital Wealth Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 19 quarters since.
U.S. Capital Wealth Advisors's Thermo Fisher Scientific position peaked at $6.62M in Q4 2021.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.